Potentiometric Probes

Potentiometric Probes

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Potentiometric Probes is a private, early-stage company commercializing a platform of voltage-sensitive dyes (VSDs) for optical electrophysiology. Its core technology, rooted in the pioneering work of co-founder Dr. Leslie Loew, offers researchers sensitive, ratiometric imaging tools to study electrical signaling in the brain, heart, and other systems without invasive electrodes. The company operates a direct-to-research sales model, providing critical chemical tools and support to accelerate basic science and pre-clinical drug screening. While currently a niche supplier, its advanced dye chemistries position it at the intersection of growing markets in functional imaging and phenotypic screening.

NeuroscienceCardiology

Technology Platform

Platform of synthetic organic voltage-sensitive dyes (VSDs), including proprietary 'ElectroFluor' compounds, that enable optical recording of membrane potential changes in cells and tissues for research and drug screening.

Opportunities

Growing demand in pharmaceutical R&D for high-throughput, functional cardiac safety screening (CiPA initiatives) represents a major commercial opportunity.
Expansion into new application areas like cancer cell electrophysiology and partnership with large life science distributors or instrument manufacturers could significantly scale the business.

Risk Factors

Competition from larger reagent companies and the rapid development of genetically encoded voltage indicators (GEVIs) poses a technological and market threat.
The company's niche focus and reliance on a limited product line create vulnerability, and commercial scaling from a boutique supplier to a broad-market player presents execution challenges.

Competitive Landscape

Competes with life science reagent giants (e.g., Thermo Fisher) offering classic VSDs and with academic labs developing genetically encoded voltage indicators (GEVIs). Differentiation is based on proprietary, performance-optimized dye chemistry (ElectroFluor series), deep application expertise, and a focus on solving specific problems like motion artifact in cardiac imaging.